» Articles » PMID: 9517649

Direct Determination of Colonic Nitric Oxide Level--a Sensitive Marker of Disease Activity in Ulcerative Colitis

Overview
Specialty Gastroenterology
Date 1998 Mar 28
PMID 9517649
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: In active ulcerative colitis, colonic nitric oxide (NO) generation is enhanced and probably has an important role in its pathogenesis. We tested the reliability of an NO electrode in monitoring colonic NO levels in ulcerative colitis patients and control subjects and its possible usage as a marker of disease activity.

Methods: Colonic NO level was determined by the NO detection system model NO-501 (InterMedical, Nagoya, Japan). The working electrode was inserted into a 7-mm diameter polyvinyl tube and introduced at a distance 6 cm from the anus. In each subject sigmoidoscopy was performed and mucosal biopsies were obtained. NO synthase (NOS) activity was determined by monitoring the conversion of 3H-arginine to citrulline.

Results: Colonic NO level is significantly increased in patients with active ulcerative or Crohn's colitis--more than 2-fold higher than in control subjects. There was good correlation between colonic NO level and NOS activity and the clinical and endoscopic indices of disease activity.

Conclusion: Direct determination of colonic NO level is convenient, and reliable, and may help to monitor disease activity in ulcerative colitis.

Citing Articles

Assessing gut barrier integrity and reproductive performance following pre-mating oral administration of solid-lipid-nanoparticles designed for drug delivery.

Lacconi V, Massimiani M, Antonello G, Gasco P, Bernardini R, Ferrari C Front Toxicol. 2025; 6():1508598.

PMID: 39839550 PMC: 11746049. DOI: 10.3389/ftox.2024.1508598.


Cardiovascular Risk in Patients with Inflammatory Bowel Diseases-The Role of Endothelial Dysfunction.

Livzan M, Bikbavova G, Lisyutenko N, Romanyuk A, Drapkina O Diagnostics (Basel). 2024; 14(16).

PMID: 39202210 PMC: 11353271. DOI: 10.3390/diagnostics14161722.


Cardiovascular manifestations of inflammatory bowel diseases and the underlying pathogenic mechanisms.

Xiao Y, Powell D, Liu X, Li Q Am J Physiol Regul Integr Comp Physiol. 2023; 325(2):R193-R211.

PMID: 37335014 PMC: 10979804. DOI: 10.1152/ajpregu.00300.2022.


Interventions of natural and synthetic agents in inflammatory bowel disease, modulation of nitric oxide pathways.

Kamalian A, Sohrabi Asl M, Dolatshahi M, Afshari K, Shamshiri S, Roudsari N World J Gastroenterol. 2020; 26(24):3365-3400.

PMID: 32655263 PMC: 7327787. DOI: 10.3748/wjg.v26.i24.3365.


Heparin-Coated Albumin Nanoparticles for Drug Combination in Targeting Inflamed Intestine.

Zhang S, Cho W, Jin A, Kok L, Shi Y, Heller D Adv Healthc Mater. 2020; 9(16):e2000536.

PMID: 32597571 PMC: 7482138. DOI: 10.1002/adhm.202000536.